Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort.

Mazières, J

Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Feb 2016 - 281-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1569-8041

10.1093/annonc/mdv573 doi


Adenocarcinoma--drug therapy
Adenocarcinoma of Lung
Adult
Afatinib
Aged
Aged, 80 and over
Anaplastic Lymphoma Kinase
Antineoplastic Agents--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cohort Studies
Disease-Free Survival
ErbB Receptors--genetics
Europe
Female
Humans
Lapatinib
Lung Neoplasms--drug therapy
Male
Middle Aged
Molecular Targeted Therapy--methods
Quinazolines--therapeutic use
Quinolines--therapeutic use
Receptor Protein-Tyrosine Kinases--genetics
Receptor, ErbB-2--genetics
Retrospective Studies
Trastuzumab--therapeutic use
Treatment Outcome